{
  "trial_id": "NCT00735969",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age 18 years or above, male or female",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Documented relapse or non-response to a prior adequate course of peginterferon and ribavirin",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Genotype 1 HCV as determined by probe specific hybridization (Inno-Lipa assay).",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Written informed consent.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Age greater than 65 years",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Decompensated liver disease, as marked by serum bilirubin greater than 4 mg percent, albumin less than 3.0 gm percent, prothrombin time greater than 2 sec prolonged, or history of bleeding esophageal varices, ascites or hepatic encephalopathy.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Serum Alanine transaminase (ALT) or Aspartate transaminase (AST) levels greater than 1000 U/L (greater than 25 times the ULN).",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Pregnancy or, in women of child bearing potential or in spouses of pregnant women, inability to practice adequate contraception.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has chronic HCV infection and is on combination therapy with IFN and RBV. He does not have any contraindications for the trial.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT00735969",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}